Literature DB >> 20352388

Retrospective analysis of infection rate after early reoperation in total hip arthroplasty.

Hussein Darwiche1, Wael K Barsoum, Alison Klika, Viktor E Krebs, Robert Molloy.   

Abstract

BACKGROUND: Infection is a devastating complication of total hip arthroplasty (THA). Unavoidable reoperation during the acute recovery phase of hip arthroplasty has the potential for an increased infection rate but the risk is not well established nor is the fate of these infected hips. QUESTIONS/PURPOSES: We therefore report the infection rate for patients undergoing THA who returned to the operating room within 90 days of his or her index procedure for any surgical intervention on the same hip.
METHODS: We identified 60 patients undergoing THA referred to or treated at our institution who required an unplanned and unavoidable return to the operating room during the acute recovery phase. The complications of the initial surgery that resulted in reoperation included instability, periprosthetic fracture, retained hardware, and nerve exploration. We then retrospectively reviewed the medical records to determine the infection rate and implant survivorship. The minimum followup was 1 month (average, 3.7 years; range, 1 month to 7 years) and included all patients who required resection before a minimum 2-year followup.
RESULTS: The infection rate for this cohort was 20 of 60 (33%). Six of these 20 retained their implants at 2 years after the reoperation and were considered infection-free. Two-stage reimplantation or resection was eventually performed in 14 of the infected patients.
CONCLUSIONS: A high percentage of patients undergoing THA developed a deep infection after unavoidable reoperation during the acute recovery phase. The reasons for the reoperations were potentially modifiable complications and situations that deserve further investigation to delineate protocols to minimize the risk of infection in these patients. LEVEL OF EVIDENCE: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2010        PMID: 20352388      PMCID: PMC2919867          DOI: 10.1007/s11999-010-1325-5

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

Review 1.  Evaluation and treatment of infection at the site of a total hip or knee arthroplasty.

Authors:  A D Hanssen; J A Rand
Journal:  Instr Course Lect       Date:  1999

2.  Optimal timeframe for reporting short-term complication rates after total knee arthroplasty.

Authors:  Nelson Fong Soohoo; David S Zingmond; Jay R Lieberman; Clifford Y Ko
Journal:  J Arthroplasty       Date:  2006-08       Impact factor: 4.757

3.  Periprosthetic infection: what are the diagnostic challenges?

Authors:  Javad Parvizi; Elie Ghanem; Sarah Menashe; Robert L Barrack; Thomas W Bauer
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

4.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

5.  The epidemiology of revision total hip arthroplasty in the United States.

Authors:  Kevin J Bozic; Steven M Kurtz; Edmund Lau; Kevin Ong; Thomas P Vail; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2009-01       Impact factor: 5.284

6.  The economic impact of infected joint arthroplasty.

Authors:  T P Sculco
Journal:  Orthopedics       Date:  1995-09       Impact factor: 1.390

7.  Differences in outcomes of obese women and men undergoing primary total hip arthroplasty.

Authors:  Anne Lübbeke; Richard Stern; Guido Garavaglia; Line Zurcher; Pierre Hoffmeyer
Journal:  Arthritis Rheum       Date:  2007-03-15

8.  Infection burden for hip and knee arthroplasty in the United States.

Authors:  Steven M Kurtz; Edmund Lau; Jordana Schmier; Kevin L Ong; Ke Zhao; Javad Parvizi
Journal:  J Arthroplasty       Date:  2008-04-10       Impact factor: 4.757

9.  Early return to surgery for evacuation of a postoperative hematoma after primary total knee arthroplasty.

Authors:  Daniel D Galat; Scott C McGovern; Arlen D Hanssen; Dirk R Larson; Jeffrey R Harrington; Henry D Clarke
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

10.  Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties.

Authors:  Kafai Lai; Eric R Bohm; Colin Burnell; David R Hedden
Journal:  J Arthroplasty       Date:  2007-08       Impact factor: 4.757

View more
  12 in total

1.  Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating.

Authors:  Mangal Roy; Gary A Fielding; Haluk Beyenal; Amit Bandyopadhyay; Susmita Bose
Journal:  ACS Appl Mater Interfaces       Date:  2012-02-28       Impact factor: 9.229

2.  The ACS NSQIP Risk Calculator Is a Fair Predictor of Acute Periprosthetic Joint Infection.

Authors:  Nathaniel C Wingert; James Gotoff; Edgardo Parrilla; Robert Gotoff; Laura Hou; Elie Ghanem
Journal:  Clin Orthop Relat Res       Date:  2016-07       Impact factor: 4.176

3.  Chronic periprosthetic hip infection: micro-organisms responsible for infection and re-infection.

Authors:  Nikolai M Kliushin; Artem M Ermakov; Tatiana A Malkova
Journal:  Int Orthop       Date:  2016-11-17       Impact factor: 3.075

4.  Development of a broad spectrum polymer-released antimicrobial coating for the prevention of resistant strain bacterial infections.

Authors:  K D Sinclair; T X Pham; R W Farnsworth; D L Williams; C Loc-Carrillo; L A Horne; S H Ingebretsen; R D Bloebaum
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

5.  Percutaneous adjustment method for transversely migrated spinal cord stimulation leads: a technical report.

Authors:  Sang Yoon Jeon; Jae Young Ji; Sie Hyeon Yoo; Jin Young Chon; Sung Hoon Jung; Ho Sik Moon
Journal:  J Anesth       Date:  2015-06-21       Impact factor: 2.078

Review 6.  Aggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements.

Authors:  Andrea Volpin; Mohamed Sukeik; Sulaiman Alazzawi; Fares Sami Haddad
Journal:  Open Orthop J       Date:  2016-11-30

Review 7.  Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.

Authors:  Qichan Hu; Melanie Ecker
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

8.  Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection.

Authors:  John R Wickman; Daniel E Goltz; Jay M Levin; Tally Lassiter; Oke A Anakwenze; Christopher S Klifto
Journal:  JSES Int       Date:  2021-08-05

9.  In vitro assessment of nanosilver-functionalized PMMA bone cement on primary human mesenchymal stem cells and osteoblasts.

Authors:  Linda Pauksch; Sonja Hartmann; Gabor Szalay; Volker Alt; Katrin S Lips
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Revision Total Hip Arthroplasty in Solid Organ Transplant Patients: A Propensity Score-Matched Cohort Study for Aseptic and Infected Revisions.

Authors:  Alex Upfill-Brown; Christopher M Hart; Peter P Hsiue; Kadarius Burgess; Clark J Chen; Amir Khoshbin; Christos Photopoulos; Alexandra I Stavrakis
Journal:  Arthroplast Today       Date:  2022-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.